Literature DB >> 29461277

Clinical Relevance of Histopathologic Analysis of HeartMate II Thrombi.

Lisa Baumann Kreuziger1,2, Mark S Slaughter3, Kartik Sundareswaran4, Alan E Mast1.   

Abstract

Left ventricular assist device (LVAD) thrombosis is a devastating complication that occurs in about 10% of patients despite anticoagulation and antiplatelet treatment. How the thrombus initiates and propagates is unknown. We pathologically and immunohistochemically examined 28 thrombi removed from 17 HeartMate II LVADs. Two groups of thrombi were found: those formed in the inlet/outlet and those on the rotor. The four thrombi found at the inlet (three inlet conduit and one inlet tube) and outlet (three at outlet elbow and one outlet graft) appeared similar and were composed of a loose meshwork of fibrin(ogen), von Willebrand factor, leukocytes, and aggregated platelets. The majority of the thrombi (20/28), however, were located on the rotor: nine at the inlet bearing, five on the rotor vanes, and six at the outlet bearing. Laminated thrombi formed around the inlet bearing in rings, an area of blood recirculation. The inner rings of the thrombus had fibrin and von Willebrand factor. Aggregated platelets were found in the outer thrombi rings, but limited evidence of platelets within the laminated thrombi was noted. The presence of distinct rings suggests development of the clot over time. The increased platelets in the outer rings of the inlet bearing thrombi would support further investigation into their role in thrombus growth. Initiating events require further investigation, but the fibrin-rich structure of HeartMate II thrombi suggests that alternative anticoagulation strategies are needed to prevent thrombosis in our LVAD patients.

Entities:  

Mesh:

Year:  2018        PMID: 29461277      PMCID: PMC6093800          DOI: 10.1097/MAT.0000000000000759

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  35 in total

1.  Studies on the character and staining of fibrin.

Authors:  A C LENDRUM; D S FRASER; W SLIDDERS; R HENDERSON
Journal:  J Clin Pathol       Date:  1962-09       Impact factor: 3.411

Review 2.  Dynamics in thrombus formation.

Authors:  E Falk
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

3.  Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation.

Authors:  Keith D Aaronson; Mark S Slaughter; Leslie W Miller; Edwin C McGee; William G Cotts; Michael A Acker; Mariell L Jessup; Igor D Gregoric; Pranav Loyalka; O H Frazier; Valluvan Jeevanandam; Allen S Anderson; Robert L Kormos; Jeffrey J Teuteberg; Wayne C Levy; David C Naftel; Richard M Bittman; Francis D Pagani; David R Hathaway; Steven W Boyce
Journal:  Circulation       Date:  2012-05-22       Impact factor: 29.690

Review 4.  Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.

Authors:  L M Baumann Kreuziger; B Kim; G M Wieselthaler
Journal:  J Thromb Haemost       Date:  2015-05-09       Impact factor: 5.824

5.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Authors:  David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

Review 6.  Medical device-induced thrombosis: what causes it and how can we prevent it?

Authors:  I H Jaffer; J C Fredenburgh; J Hirsh; J I Weitz
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

7.  Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.

Authors:  A S Savchenko; K Martinod; M A Seidman; S L Wong; J I Borissoff; G Piazza; P Libby; S Z Goldhaber; R N Mitchell; D D Wagner
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

8.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

Review 9.  Update on acute coronary syndromes: the pathologists' view.

Authors:  Erling Falk; Masataka Nakano; Jacob Fog Bentzon; Aloke V Finn; Renu Virmani
Journal:  Eur Heart J       Date:  2012-12-13       Impact factor: 29.983

10.  Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit.

Authors:  S Honda; Y Tomiyama; A J Pelletier; D Annis; Y Honda; R Orchekowski; Z Ruggeri; T J Kunicki
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

View more
  5 in total

1.  A Continuum Model for the Unfolding of von Willebrand Factor.

Authors:  Mansur Zhussupbekov; Rodrigo Méndez Rojano; Wei-Tao Wu; Mehrdad Massoudi; James F Antaki
Journal:  Ann Biomed Eng       Date:  2021-08-16       Impact factor: 3.934

2.  Influence of shear rate and surface chemistry on thrombus formation in micro-crevice.

Authors:  Mansur Zhussupbekov; Wei-Tao Wu; Megan A Jamiolkowski; Mehrdad Massoudi; James F Antaki
Journal:  J Biomech       Date:  2021-03-26       Impact factor: 2.789

3.  Accumulations of von Willebrand factor within ECMO oxygenators: Potential indicator of coagulation abnormalities in critically ill patients?

Authors:  Tamara Steiger; Maik Foltan; Alois Philipp; Thomas Mueller; Michael Gruber; Andre Bredthauer; Lars Krenkel; Clemens Birkenmaier; Karla Lehle
Journal:  Artif Organs       Date:  2019-07-30       Impact factor: 3.094

4.  A fibrin enhanced thrombosis model for medical devices operating at low shear regimes or large surface areas.

Authors:  Rodrigo Méndez Rojano; Angela Lai; Mansur Zhussupbekov; Greg W Burgreen; Keith Cook; James F Antaki
Journal:  PLoS Comput Biol       Date:  2022-10-03       Impact factor: 4.779

Review 5.  Hemostatic complications associated with ventricular assist devices.

Authors:  Talal Hilal; James Mudd; Thomas G DeLoughery
Journal:  Res Pract Thromb Haemost       Date:  2019-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.